2011-2017
During my PhD at EPFL (Lausanne, Switzerland), I identified factors governing differentiation and metastasis of lung adenocarcinoma. This resulted in unraveling the crucial role of Receptor interacting Serine/Threonine kinase 4 (RIP4) in regulation of STAT3 activation and remodeling of lung adenocarcinoma microenvironment.
2010-2011
During my Internship, I worked on developing nanoparticle-based therapy to study the effect of acute versus temporal inhibition of PI3 kinase pathway on therapy resistance in breast cancer.
